Charted
Sunday, Nov. 22, 2026The business of health, by the numbers
Live trackersDeal tracker $50.9B raisedFDA clearances 293 510(k)s in OctoberForm D raises $1.4B in 30 daysNew trials 248 Phase 2/3 in 30 days
№01·Payers & Policy

The week in health deals and policy: Medicare Advantage plans face audits and ratings overhaul

CMS proposed a fraud rule and a Star Ratings rewrite that both reach Medicare Advantage insurers. In the same week, J&J, Lilly and private investors put billions into drug programs that have no late-stage data.

Sara Montes de OcaNov. 22 · 3 min read
A scientist at the National Center for Advancing Translational Sciences calibrates a robot that prepares drug combinations for automated screening. File photo.National Center for Advancing Translational Sciences (public domain)

The Latest

Nov. 17 – Nov. 213 stories

Earlier

Nov. 173 stories
Deal tracker
$50.9Braised

Disclosed funding across 527 venture rounds, IPOs, private placements and Form D raises tracked since Jan. 6. The tracker also lists 103 acquisitions; those priced in dollars total $239B.

FDA clearances
293510(k)s in October

FDA cleared 293 devices through the 510(k) pathway in October 2026, 8% fewer than the month before. The busiest review panels were orthopedic (42), general, plastic surgery (40), cardiovascular (34).

Form D raises
$1.4Bin 30 days

114 health-care companies reported selling $1.4B in private offerings on new Form D filings in the past 30 days. By industry: other health care 52, biotechnology 49, pharmaceuticals 9, hospitals and physicians 4.

New trials
248Phase 2/3 in 30 days

Companies registered 248 new Phase 2 or Phase 3 interventional trials on ClinicalTrials.gov in the past 30 days, 108 of them Phase 3.

DateCompanyTypeAmountLed by / buyerSector
Nov. 19Laza MedicalForm D$70.5MBiotech
Nov. 19InflammatixForm D$47.4MBiotech
Nov. 18Rising Tide Dental HoldingsForm D$61.7MOther Health Care
Nov. 18Ansa BiotechnologiesSeries C$71.5MBlue Water Life Science AdvisorsBiotech
Nov. 17Marrow TherapeuticsSeries B$173MOrbiMed, Scion Life Sciences, venBioBiotech
Nov. 17ODAIASeries C$15MMonograph CapitalHealth AI
Nov. 17Isomorphic LabsSeries C$5BGreenoaks, Sequoia CapitalBiotech
Nov. 17ScienceSeries D$400MMedtech
Nov. 17Onward TherapeuticsSeries B$28MBiotech
Nov. 17Commit BiologicsSeed$60MAckermans & van HaarenBiotech
Newsletter

Charted Daily

The day's deals, FDA decisions and policy moves, by the numbers. Free. Sign up now to get the first edition.

No spam. Unsubscribe any time.